Viewing Study NCT03496233


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT03496233
Status: COMPLETED
Last Update Posted: 2023-02-22
First Post: 2018-02-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients
Sponsor: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module